Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 10—October 2007
Dispatch

Borrelia burgdorferi Infection and Cutaneous Lyme Disease, Mexico

Guadalupe Gordillo-Pérez*, Javier Torres*, Fortino Solórzano-Santos*, Sylvie de Martino†, Dan Lipsker†, Edmundo Velázquez*, Guillermo Ramon*, Muñoz Onofre*, and Benoit Jaulhac†
Author affiliations: *Instituto Mexicano del Seguro Social, Mexico City, Mexico; †Hôpitaux Universitaires, Strasbourg, France;

Main Article

Figure 1

Western Blot (WB) immunoglobulin G results from cutaneous cases. A) WB with serum from patient 1, showing erythema migrans (arrow). B) WB with serum from patient 4, showing lymphocytoma (arrow); a strong positive and a weak positive control were included.

Figure 1. Western Blot (WB) immunoglobulin G results from cutaneous cases. A) WB with serum from patient 1, showing erythema migrans (arrow). B) WB with serum from patient 4, showing lymphocytoma (arrow); a strong positive and a weak positive control were included.

Main Article

Page created: July 02, 2010
Page updated: July 02, 2010
Page reviewed: July 02, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external